Published in BMC Psychiatry on September 26, 2012
A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder | NCT04210804
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry (2016) 0.99
Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast (2014) 0.83
The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder. Neural Plast (2015) 0.78
Inflammatory markers among adolescents and young adults with bipolar spectrum disorders. J Clin Psychiatry (2015) 0.78
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2003) 3.60
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry (2003) 3.59
Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry (2000) 2.96
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry (2009) 1.70
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev (2011) 1.58
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res (1999) 1.33
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord (2009) 1.32
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol (2008) 1.30
Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res (2010) 1.10
Cytokines in bipolar disorder: a systematic review and meta-analysis. J Affect Disord (2012) 1.08
Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2010) 1.06
Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr (2011) 1.03
TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.99
Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers. J Affect Disord (2012) 0.96
Cytokine levels in euthymic bipolar patients. J Affect Disord (2010) 0.93
The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicology (2009) 0.91
The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.90
Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res (2012) 0.90
Increased levels of adipokines in bipolar disorder. J Psychiatr Res (2011) 0.88
The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. J Affect Disord (2008) 0.88
The importance of subsyndromal symptoms in bipolar disorder. J Clin Psychiatry (2004) 0.87
Evidence for an association between tumor necrosis factor-alpha levels and lithium response. J Affect Disord (2012) 0.81
Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort study. J Affect Disord (2010) 0.81
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ (2011) 3.84
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev (2010) 3.77
Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull (2012) 3.46
"Schizophrenia" does not exist. BMJ (2016) 3.34
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ (2004) 2.93
Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study. Addiction (2013) 2.46
Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants. Am J Psychiatry (2007) 2.45
Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Am J Psychiatry (2006) 2.44
A salience dysregulation syndrome. Br J Psychiatry (2009) 2.23
The effects of FreeSurfer version, workstation type, and Macintosh operating system version on anatomical volume and cortical thickness measurements. PLoS One (2012) 2.18
Early expression of negative/disorganized symptoms predicting psychotic experiences and subsequent clinical psychosis: a 10-year study. Am J Psychiatry (2010) 2.10
Does the urban environment cause psychosis? Br J Psychiatry (2004) 2.10
Should attenuated psychosis syndrome be a DSM-5 diagnosis? Am J Psychiatry (2011) 2.02
The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol (2005) 2.00
Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol (2005) 1.96
Relationship between CD107a expression and cytotoxic activity. Cell Immunol (2008) 1.95
Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull (2009) 1.93
The environment and schizophrenia: the role of cannabis use. Schizophr Bull (2005) 1.90
Schizophrenia and urbanicity: a major environmental influence--conditional on genetic risk. Schizophr Bull (2005) 1.88
Children's health-related quality of life, neighbourhood socio-economic deprivation and social capital. A contextual analysis. Soc Sci Med (2003) 1.86
Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry (2010) 1.81
Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res (2002) 1.80
Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev (2007) 1.78
Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res (2007) 1.77
Cannabis use and expression of mania in the general population. J Affect Disord (2006) 1.76
Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study. Br J Psychiatry (2010) 1.75
Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry (2006) 1.74
Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry (2008) 1.70
Efficacy of mindfulness-based cognitive therapy in relation to prior history of depression: randomised controlled trial. Br J Psychiatry (2012) 1.70
Childhood trauma as a cause of psychosis: linking genes, psychology, and biology. Can J Psychiatry (2013) 1.66
Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res (2005) 1.64
Childhood trauma and emotional reactivity to daily life stress in adult frequent attenders of general practitioners. J Psychosom Res (2006) 1.63
Pediatric illness severity measures predict delirium in a pediatric intensive care unit. Crit Care Med (2008) 1.60
Psychopathological mechanisms linking childhood traumatic experiences to risk of psychotic symptoms: analysis of a large, representative population-based sample. Schizophr Bull (2014) 1.59
Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med (2007) 1.57
The BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: An attempt at replication. Am J Med Genet B Neuropsychiatr Genet (2008) 1.55
Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endophenotypes. Br J Psychiatry (2005) 1.55
Determinants of occurrence and recovery from hallucinations in daily life. Soc Psychiatry Psychiatr Epidemiol (2002) 1.53
Effectively working on rehabilitation goals: 24-month outcome of a randomized controlled trial of the Boston psychiatric rehabilitation approach. Can J Psychiatry (2011) 1.51
The epigenome and postnatal environmental influences in psychotic disorders. Soc Psychiatry Psychiatr Epidemiol (2014) 1.51
Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research. Schizophr Bull (2012) 1.50
Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VII. Annu Rev Clin Psychol (2010) 1.44
Catatonia in DSM-5. Schizophr Res (2013) 1.43
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42
Metabolic syndrome prevalence in different affective temperament profiles in bipolar-I disorder. Rev Bras Psiquiatr (2013) 1.41
Managing complex patients on a medical psychiatric unit: an observational study of university hospital costs associated with medical service use, length of stay, and psychiatric intervention. J Psychosom Res (2009) 1.40
Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. Br J Psychiatry (2006) 1.40
Jaspers was right after all--delusions are distinct from normal beliefs. Against. Br J Psychiatry (2003) 1.40
Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun (2010) 1.36
Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Arch Gen Psychiatry (2012) 1.35
Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol (2010) 1.34
A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial. World Psychiatry (2014) 1.33
Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull (2009) 1.32
Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol Psychiatry (2010) 1.32
Emotions, self-esteem, and paranoid episodes: an experience sampling study. Br J Clin Psychol (2011) 1.32
Psychiatric diagnosis revisited: towards a system of staging and profiling combining nomothetic and idiographic parameters of momentary mental states. PLoS One (2013) 1.31
Childhood trauma and psychosis: a case-control and case-sibling comparison across different levels of genetic liability, psychopathology, and type of trauma. Am J Psychiatry (2011) 1.30
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology (2006) 1.29
A time-lagged momentary assessment study on daily life physical activity and affect. Health Psychol (2011) 1.29
Training and practice of psychotherapy in Europe: results of a survey. World Psychiatry (2011) 1.28
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr Res (2010) 1.26
Data gathering: biased in psychosis? Schizophr Bull (2005) 1.24
Atypical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord (2006) 1.23
Mindfulness training increases momentary positive emotions and reward experience in adults vulnerable to depression: a randomized controlled trial. J Consult Clin Psychol (2011) 1.23
Childhood victimisation and developmental expression of non-clinical delusional ideation and hallucinatory experiences: victimisation and non-clinical psychotic experiences. Soc Psychiatry Psychiatr Epidemiol (2006) 1.23
Effect of COMT Val158Met polymorphism on the Continuous Performance Test, Identical Pairs Version: tuning rather than improving performance. Am J Psychiatry (2005) 1.23
Evidence that moment-to-moment variation in positive emotions buffer genetic risk for depression: a momentary assessment twin study. Acta Psychiatr Scand (2007) 1.22
Refractory agitation as a marker for pediatric delirium in very young infants at a pediatric intensive care unit. Intensive Care Med (2010) 1.22
The structure of the extended psychosis phenotype in early adolescence--a cross-sample replication. Schizophr Bull (2009) 1.21
On the utility of diagnostic instruments for pediatric delirium in critical illness: an evaluation of the Pediatric Anesthesia Emergence Delirium Scale, the Delirium Rating Scale 88, and the Delirium Rating Scale-Revised R-98. Intensive Care Med (2011) 1.20
Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res (2006) 1.19
Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophr Res (2007) 1.19
Evidence that onset of psychosis in the population reflects early hallucinatory experiences that through environmental risks and affective dysregulation become complicated by delusions. Schizophr Bull (2010) 1.18
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin Exp Metastasis (2005) 1.18
An observational, "real life" trial of the introduction of assertive community treatment in a geographically defined area using clinical rather than service use outcome criteria. Soc Psychiatry Psychiatr Epidemiol (2007) 1.18
A real-life observational study of the effectiveness of FACT in a Dutch mental health region. BMC Psychiatry (2008) 1.17
Rumination and worrying as possible mediators in the relation between neuroticism and symptoms of depression and anxiety in clinically depressed individuals. Behav Res Ther (2008) 1.15
Emotional experience in negative symptoms of schizophrenia--no evidence for a generalized hedonic deficit. Schizophr Bull (2011) 1.15
Children's mental health service use, neighbourhood socioeconomic deprivation, and social capital. Soc Psychiatry Psychiatr Epidemiol (2003) 1.15
Fluctuations in self-esteem and paranoia in the context of daily life. J Abnorm Psychol (2008) 1.14
Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol Bull (2009) 1.14
Phenotypically continuous with clinical psychosis, discontinuous in need for care: evidence for an extended psychosis phenotype. Schizophr Bull (2011) 1.14
Transition from stress sensitivity to a depressive state: longitudinal twin study. Br J Psychiatry (2009) 1.13
The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life. Neuropsychopharmacology (2007) 1.12
Association between short birth intervals and schizophrenia in the offspring. Schizophr Res (2004) 1.12
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
MTHFR and risk of metabolic syndrome in patients with schizophrenia. Schizophr Res (2010) 1.10
Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment. Psychol Med (2006) 1.09
Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. Br J Clin Psychol (2005) 1.09
Affectively salient meaning in random noise: a task sensitive to psychosis liability. Schizophr Bull (2010) 1.08
Alterations in theory of mind in patients with schizophrenia and non-psychotic relatives. Acta Psychiatr Scand (2003) 1.07
Maternal C-reactive protein and schizophrenia. Am J Psychiatry (2015) 1.07
Neuroticism and low self-esteem as risk factors for psychosis. Soc Psychiatry Psychiatr Epidemiol (2002) 1.06
Redeeming diagnosis in psychiatry: timing versus specificity. Lancet (2013) 1.06
Testing the psychosis continuum: differential impact of genetic and nongenetic risk factors and comorbid psychopathology across the entire spectrum of psychosis. Schizophr Bull (2011) 1.05